1
|
Spinardi J, Dantas AC, Carballo C, Thakkar K, Akoury NA, Kyaw MH, Del Carmen Morales Castillo G, Srivastava A, Sáfadi MAP. Narrative Review of the Evolution of COVID-19 Vaccination Recommendations in Countries in Latin America, Africa and the Middle East, and Asia. Infect Dis Ther 2023; 12:1237-1264. [PMID: 37097556 PMCID: PMC10127189 DOI: 10.1007/s40121-023-00804-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/19/2023] [Accepted: 04/03/2023] [Indexed: 04/26/2023] Open
Abstract
The rapid rollout of vaccines to combat the coronavirus disease 2019 (COVID-19) pandemic over the past 2 years has resulted in the use of various vaccine platforms and regional differences in COVID-19 vaccine implementation strategies. The aim of this narrative review was to summarize evolving COVID-19 vaccine recommendations in countries in Latin America, Asia, and Africa and the Middle East across various vaccine platforms, age groups, and specific subpopulations. Nuances in primary and booster vaccination schedules were evaluated, and the preliminary impact of such diverse vaccination strategies are discussed, including key vaccine effectiveness data in the era of Omicron-lineage variants. Primary vaccination rates for included Latin American countries were 71-94% for adults and between 41% and 98% for adolescents and children; rates for first booster in adults were 36-85%. Primary vaccination rates for adults in the included Asian countries ranged from 64% in the Philippines to 98% in Malaysia, with corresponding booster rates varying from 9% in India to 78% in Singapore; for adolescents and children, primary vaccination rates ranged from 29% in the Philippines to 93% in Malaysia. Across included African and Middle Eastern countries, primary vaccination rates in adults varied widely from 32% in South Africa to 99% in the United Arab Emirates; booster rates ranged from 5% in South Africa to 60% in Bahrain. Evidence from the regions studied indicates preference of using an mRNA vaccine as a booster on the basis of safety and effectiveness of observed real-world data, especially during circulation of Omicron lineages. Vaccination against COVID-19 remains of paramount importance to reduce the burden of disease; strategies to overcome vaccine inequity, fatigue, hesitancy, and misinformation and to ensure adequate access and supply are also important.
Collapse
Affiliation(s)
- Júlia Spinardi
- Vaccine Medical and Scientific Affairs, Pfizer, Rua Alexandre Dumas, 1860, São Paulo, 04717904, Brazil.
- Santa Casa de São Paulo School of Medical Sciences, São Paulo, Brazil.
| | | | | | - Karan Thakkar
- Vaccines Medical Affairs, Pfizer, Singapore, Singapore
| | | | - Moe Hein Kyaw
- Vaccines Clinical Epidemiologist Emerging Markets, Pfizer Inc, Collegeville, PA, USA
| | | | | | - Marco Aurélio P Sáfadi
- Department of Pediatrics, Santa Casa de São Paulo School of Medical Sciences, São Paulo, Brazil
| |
Collapse
|
2
|
Dantas AC, Torres GDSD, Corrêa CDC, Pinto FCDA, Cera M. Categories of the International Classification of Functioning, Disability and Health in studies of people with aphasia: a scoping review. Rev CEFAC 2022. [DOI: 10.1590/1982-0216/20222426921] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
Abstract
ABSTRACT Purpose: to identify, through a scoping review, the categories of the International Classification of Functioning, Disability and Health described in studies on aphasia. Methods: the search was performed by DECs, MeSH terms and free terms related to the “International Classification of Functioning, Disability and Health” and “aphasia” in five databases, EMBASE, LILACS, PubMed, Scopus and Web of Science, and four search engines of grey literature. The PRISMA recommendations were used. EndNote and Rayyan managers were used to remove duplicates and read titles, abstracts and full studies. Papers that contained “aphasia” and some aspect from the International Classification of Functioning, Disability and Health were eligible, published from 2001. The data recorded were: type of study, level of evidence, sample, objectives and categories. Literature Review: 1,366 studies were located in the databases and 341 in the grey literature. The mostly described first level categories in the 13 selected studies were: Structures of the Nervous System (Brain); Mental Functions (Language); Communication (Conversation); Support and Relationships (Immediate Family). Gender and age were some of the most identified Personal Factors. Conclusion: this review provides support to the use of the International Classification of Functioning, Disability and Health for performance with people with aphasia.
Collapse
|
3
|
Dantas AC, Torres GDSD, Corrêa CDC, Pinto FCDA, Cera M. Categorias da Classificação Internacional de Funcionalidade, Incapacidade e Saúde na atuação com pessoas com afasia: uma revisão de escopo. Rev CEFAC 2022. [DOI: 10.1590/1982-0216/20222426921s] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
Abstract
RESUMO Objetivo: identificar, por meio de uma revisão de escopo, as categorias da Classificação Internacional de Funcionalidade, Incapacidade e Saúde descritas em estudos sobre as afasias. Métodos: foi realizada uma busca nas bases de dados EMBASE, LILACS, PubMed, Scopus e Web of Science e em quatro buscadores da literatura cinzenta a partir dos DECs, termos Mesh e termos livres relacionados à “International Classification of Functioning, Disability and Health” e à “aphasia”. As recomendações do PRISMA foram utilizadas. Os gerenciadores EndNote e Rayyan foram usados para remoção das duplicatas e para a leitura dos títulos, resumos e textos completos. Foram elegíveis os trabalhos que incluíam “afasia” e algum conceito da Classificação Internacional de Funcionalidade, Incapacidade e Saúde; publicados a partir de 2001. As informações registradas foram: tipo de estudo, nível de evidência, amostra, objetivos e categorias. Revisão de Literatura: foram localizados 1366 trabalhos nas bases de dados e 341 na literatura cinzenta. As categorias de primeiro nível mais descritas nos 13 estudos selecionados foram: Estruturas do Sistema Nervoso (Cérebro); Funções Mentais (Linguagem); Comunicação (Conversação); Apoio e Relacionamentos (Família Nuclear). Sexo e idade foram alguns dos Fatores Pessoais mais identificados. Conclusão: esta revisão fornece suporte para recomendar o uso da Classificação Internacional de Funcionalidade, Incapacidade e Saúde na atuação com pessoas com afasia.
Collapse
|